Bill
HD 2247
Overview: HD 2247, "An Act relative to pharmaceutical gag clauses", is a proposed bill that has been introduced in the legislature on November 29, 2025.Purpose and Intent: The prim
Overview: HD 2247, "An Act relative to pharmaceutical gag clauses", is a proposed bill that has been introduced in the legislature on November 29, 2025.
Purpose and Intent: The primary purpose of this bill is to prohibit the use of "gag clauses" in contracts between pharmacies and pharmaceutical companies. These clauses currently prevent pharmacists from informing patients about lower-cost medication options.
Key Provisions:
- Bans the inclusion of gag clauses in pharmacy-pharmaceutical company contracts
- Requires pharmacists to proactively inform patients about the availability of lower-cost alternative medications
- Establishes penalties for pharmaceutical companies that violate the gag clause prohibition
Affected Parties and Impacts: This bill would directly benefit consumers by empowering them to make more informed decisions about their medication options and costs. It would also support pharmacists in providing transparent and comprehensive information to their patients.
Procedural and Timeline Considerations: The bill has been introduced and is currently in the legislative process. If passed, the new requirements would take effect within 90 days of the bill becoming law.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
